Cimzia
Cimzia ingredients
| Active ingredient | Strength |
|---|---|
| Certolizumab Pegol | 200 mg/mL |
What Cimzia is used for
The FDA lists the approved uses on the official label (below). In the EU, certolizumab pegol is approved as Cimzia for:
Rheumatoid arthritis Cimzia, in combination with methotrexate (MTX), is indicated for: the treatment of moderate to severe, active rheumatoid arthritis (RA) in adult patients when the response to disease-modifying antirheumatic drugs (DMARDs) including MTX, has been inadequate. Cimzia can be given as monotherapy in case of intolerance to MTX or when continued treatment with MTX is inappropriate the treatment of severe, active and progressive RA in adults not previously treated with MTX or other DMARDs. Cimzia has been shown to reduce the rate of progression of joint damage as measured by X ray and to improve physical function, when given in combination with MTX. Axial spondyloarthritis Cimzia is indicated for the treatment of adult patients with severe active axial spondyloarthritis, comprising: Ankylosing spondylitis (AS) Adults with severe active ankylosing spondylitis who have had an …
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Cimzia
- Generic name
- Certolizumab pegol
- Made by
- UCB, Inc.
- Forms
- Injection, Solution, Kit
- Given
- Subcutaneous
- Drug class
- Tumor Necrosis Factor Blocker
- FDA approval
- Biologic licence (BLA) BLA125160
- On the US market since
- 2008
Official information
- MedlinePlus drug information (search for Certolizumab pegol)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Cimzia?
Cimzia (Certolizumab pegol) is a specialist medicine made by UCB, Inc., approved by the US FDA.
What are the ingredients of Cimzia?
Cimzia contains Certolizumab Pegol (200 mg/mL).
Is Cimzia approved in Europe?
The same active substance is approved in the EU as Cimzia.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA